Inventor · disambiguated record
Jeffrey D. Esko
Also filed as: ESKO JEFFREY · ESKO JEFFREY D
8 granted patents·10 pending applications·167 citations·filing 1990–2022
86Inventor score
Files withUNIV CALIFORNIA8TEGA THERAPEUTICS INC5ESKO JEFFREY D1GORDTS PHILIP L S M1UAB RESEARCH FOUNDATION1
Top patents by PatentIndex Score
18 records- 0188US7772192B2Compositions and methods for treatment of disease with acetylated disaccharidesUNIV CALIFORNIA·Filed 2004·Granted Aug 10, 2010·45 cites·33 claims
- 0286US5639734ADisaccharide inflammation inhibitors and uses thereofFiled 1994·Granted Jun 17, 1997·87 cites·18 claims
- 0375US9757468B2Intranasal administration of guanidinylated aminoglycosidesUNIV CALIFORNIA·Filed 2014·Granted Sep 12, 2017·3 cites·15 claims
- 0470US11549000B2Cellular glycosaminoglycan compositions and methods of making and usingTEGA THERAPEUTICS INC·Filed 2016·Granted Jan 10, 2023·1 cites·10 claims
- 0568US2024026404A1Cellular glycosaminoglycan compositions and methods of making and usingTEGA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0666US9889182B2Assisted enzyme replacement therapyESKO JEFFREY D·Filed 2010·Granted Feb 13, 2018·2 cites·22 claims
- 0758US5104856AHeparan sulfate biosynthesis primersUAB RESEARCH FOUNDATION·Filed 1990·Granted Apr 14, 1992·29 cites·7 claims
- 0857US2024053342A1Antithrombin heparan sulfate for detection and treatment of cancerUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 0952US2023277634A1Application of microbial glycosidase as an anti-viral therapeutic, prognostic, and diagnosticUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 1051US10543283B2Intranasal administration of guanidinylated aminoglycosidesUNIV CALIFORNIA·Filed 2017·Granted Jan 28, 2020·0 cites·21 claims
- 1151US2024301092A1Heparin from modified mst cells and methods of making and usingTEGA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1250US10449230B2Polymyxin derived cell penetrating scaffoldsUNIV CALIFORNIA·Filed 2017·Granted Oct 22, 2019·0 cites·17 claims
- 1348US2018311321A1Assisted enzyme replacement therapyUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 1445US2023321101A1Methods and uses of halofuginoneGORDTS PHILIP L S M·Filed 2021·Application pending·0 cites
- 1541US2018086782A1Guanidinoglycoside-mediated liposome-based delivery of therapeuticsUNIV CALIFORNIA·Filed 2016·Application pending·0 cites
- 1640US2008268013A1Polyethylene Oxide Polymers Including Anti-Inflammatory GlycodendronsUNIV EMORY·Filed 2006·Application pending·0 cites
- 1739US2022305049A1Heparin and heparan sulfate from modified mst cells and methods of making and usingTEGA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1829US2020038430A1In vitro heparin and heparan sulfate compositions and methods of making and usingTEGA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey D. Esko files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →